HTGF and IFH back KSK Diagnostics

The new funding will be used to develop point-of-care tests by using isothermal amplification technology. This should allow pathogens and anti-microbial resistance to be identified within 30 minutes, and promptly coordinate treatment, according to the company.

IFH is wholly funded with public money from the Free Hanseatic City of Hamburg and the European Regional Development Fund. HTGF, on the other hand, is backed by a mix of public and private investors. The two investors hope to accelerate product development and market entry for KSK.

Company
KSK Diagnostics was founded in 2014 and is headquartered in Hamburg. The company was founded by three doctors who have previous experience managing and selling a business. It is focused on the development of technological diagnostic solutions including the patented KDx rITA isothermal amplification technology.

People
High-tech Gründerfonds – Frank Hensel (senior investment manager).
KSK Diagnostics – Stefan Kulick (managing director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH
• Healthcare
• Venture
• High-Tech Gründerfonds
• Germany